O-Glycosylation of 4-(Substituted benzyl)-1,2-dihydro-3H-pyrazol-3-one Derivatives with 2,3,4,6-Tetra-O-acyl-α-D-glucopyranosyl Bromide via N1-Acetylation of the Pyrazole Ring

被引:7
作者
Kobayashi, Masahiro [1 ]
Isawa, Hidetoshi [2 ]
Sonehara, Junichi [2 ]
Kubota, Minoru [2 ]
Ozawa, Tetsuji [1 ]
机构
[1] Kissei Pharmaceut Co Ltd, Head Off, 19-48 Yoshino, Matsumoto, Nagano 3998710, Japan
[2] Kissei Pharmaceut Co Ltd, Proc Chem R&D, Kubiki Ku, 197-5 Kamiyoshi, Niigata 9420145, Japan
关键词
O-glycosylation; 1,2-dihydro-3H-pyrazol-3-ones derivative; N-1-acetylation; glucopyranosyloxypyrazole derivative; Remogliflozin etabonate; GLUCOSE COTRANSPORTER SGLT2; REMOGLIFLOZIN ETABONATE; INHIBITORS;
D O I
10.1248/cpb.c15-00982
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A practical preparation of 4-(substituted benzyl)-3-(2,3,4,6-tetra-O-acyl-beta-b-glucopyranosyloxy)-1H-pyrazole derivative 2 is described. O-Glycosylation of 4-(substituted benzyl)-1,2-dihydro-3H-pyrazol-3-one derivative 3 was facilitated by introduction of electron-withdrawing substituents, such as an acetyl group, at the N-1-position of the pyrazole ring. 1-Acetyl-4-(substituted benzyl)-1,2-dihydro-3H-pyrazol-3-one 10 reacted with 2,3,4,6-tetra-O-acyl-alpha-D-glucopyranosyl bromide 5 in the presence of potassium carbonate in acetonitrile to provide the 1-acetyl-4-(substituted benzyl)-3-(2,3,4,6-tetra-O-acyl-beta-6-glucopyranosyloxy)-1H-pyrazole derivative 11 in high yield. When 2,3,4,6-tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide (5b) was used as a glycosyl donor, the resulting O-glycosylated product 11 was N-1-deacetylated in the presence of potassium bicarbonate in methanol without unfavorable deprotection of the glycosyl moiety to provide 2 in excellent yield. The synthetic intermediate 2b of Remogliflozin etabonate (1b) was synthesized using this strategy.
引用
收藏
页码:1009 / 1018
页数:10
相关论文
共 17 条
[1]  
Fujikura H., 2002, PCT, Patent No. [WO 02/053573, 02053573]
[2]  
Fujikura H., 2001, Patent No. [00116147, WO 01/16147, 0116147]
[3]   Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models [J].
Fujimori, Yoshikazu ;
Katsuno, Kenji ;
Nakashima, Ikumi ;
Ishikawa-Takemura, Yukiko ;
Fujikura, Hideki ;
Isaji, Masayuki .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (01) :268-276
[4]  
Isaji M, 2007, CURR OPIN INVEST DR, V8, P285
[5]   THE HUMAN KIDNEY LOW-AFFINITY NA+/GLUCOSE COTRANSPORTER SGLT2 - DELINEATION OF THE MAJOR RENAL REABSORPTIVE MECHANISM FOR D-GLUCOSE [J].
KANAI, Y ;
LEE, WS ;
YOU, GF ;
BROWN, D ;
HEDIGER, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :397-404
[6]   Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level [J].
Katsuno, Kenji ;
Fujimori, Yoshikazu ;
Takemura, Yukiko ;
Hiratochi, Masahiro ;
Itoh, Fumiaki ;
Komatsu, Yoshimitsu ;
Fujikura, Hideki ;
Isaji, Masayuki .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01) :323-330
[7]   New potent antihyperglycemic agents in db/db mice: Synthesis and structure-activity relationship studies of (4-substituted benzyl)(trifluoromethyl)pyrazoles and -pyrazolones [J].
Kees, KL ;
Fitzgerald, JJ ;
Steiner, KE ;
Mattes, JF ;
Mihan, B ;
Tosi, T ;
Mondoro, D ;
McCaleb, ML .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) :3920-3928
[8]  
Kraemer G., 2007, PCT, Patent No. [WO 2007/080170, 2007080170]
[9]  
Kyu Y.Y., 1989, B KOREAN CHEM SOC, V10, P112
[10]   Stereoselective C-Glycosylation Reactions with Arylzinc Reagents [J].
Lemaire, Sebastien ;
Houpis, Ioannis N. ;
Xiao, Tingting ;
Li, Juanjuan ;
Digard, Eric ;
Gozlan, Charlotte ;
Liu, Renmao ;
Gavryushin, Andrey ;
Diene, Coura ;
Wang, Youchu ;
Farina, Vittorio ;
Knochel, Paul .
ORGANIC LETTERS, 2012, 14 (06) :1480-1483